You have 9 free searches left this month | for more free features.

Menin

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

ALL, Adult, AML, Adult Trial (BN104)

Not yet recruiting
  • ALL, Adult
  • AML, Adult
  • (no location specified)
Sep 19, 2023

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Type 2 Diabetes Trial in Canada, United States (BMF-219)

Recruiting
  • Type 2 Diabetes Mellitus
  • Montclair, California
  • +5 more
Feb 22, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Type 1 Diabetes Trial (BMF-219)

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • (no location specified)
Nov 21, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • Solid Tumors
  • (no location specified)
Feb 15, 2023

Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

Recruiting
  • Relapsed/Refractory Leukemias
  • +4 more
  • Kansas City, Missouri
  • +1 more
Jul 18, 2022

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

Temporomandibular Disorders Trial (Botulinum toxin type A, Isotonic saline 0,9%)

Not yet recruiting
  • Temporomandibular Disorders
  • Botulinum toxin type A
  • Isotonic saline 0,9%
  • (no location specified)
Jan 30, 2023

Depression, Anxiety, Quality of Life, Cancer Trial (Acceptance and Commitment Therapy, Psychoeducation Active Control)

Not yet recruiting
  • Depression, Anxiety
  • +2 more
  • Acceptance and Commitment Therapy
  • Psychoeducation Active Control
  • (no location specified)
Oct 17, 2022

MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

Not yet recruiting
  • MEN1 Gene Mutation
  • Leflunomide 20 mg
  • Basel, Switzerland
    Unispital Basel
Nov 1, 2022

Overall Survival of Large Cell Neuroendocrine Lung Cancer

Completed
  • Survival Outcomes of Patients With Pulmonary LCNEC
    • (no location specified)
    Jun 27, 2019

    Type 1 Multiple Endocrine Neoplasia Cohort Study

    Unknown status
    • Type 1-Multiple Endocrine Neoplasia Syndrome
      • Dijon, France
        Chu Dijon Bourgogne
      Aug 23, 2017

      Diffuse Large B Cell Lymphoma Trial (Rituximab, Bendamustine, Cytarabine)

      Unknown status
      • Diffuse Large B Cell Lymphoma
      • (no location specified)
      May 3, 2016